Our pipeline includes several targeted immuno-oncology therapies for difficult-to-treat cancers (select a program to learn more).
Learn more about our THIO Program
Learn more about our Second-Generation Programs
1 Phase 2 Basket / Umbrella design – for accelerated approval in U.S.
2 Phase 2/3 Basket study – for confirmatory / definitive approval in: Colorectal Cancer (CRC), Small Cell Lung Cancer (SCLC), Hepatocellular Carcinoma (HCC), Glioblastoma (GBM), Melanoma, Ovarian, Pancreatic, Breast, Prostate, and Gastric cancers